Clinical Trials Logo

Pulmonary Edema clinical trials

View clinical trials related to Pulmonary Edema.

Filter by:

NCT ID: NCT01455766 Completed - Pneumonectomy Clinical Trials

Volumetric Monitoring in Major Lung Surgery

EVLW-PNEUMO
Start date: June 2005
Phase: N/A
Study type: Observational

The hypothesis of this observational single-center clinical study was to explore the volumetric hemodynamic monitoring in the perioperative period in major and risky thoracic intervention. The investigators monitored the changes in the volumes of blood in the central vessels and heart chambers as well as a volume of fluid in pulmonary tissue (i. e. extravascular lung water).

NCT ID: NCT01277679 Completed - Clinical trials for Heart Failure, Congestive

Evaluation of MRI Measures of Lung Water With Posture Changes in Healthy Volunteers and in Patients With Cardiac Failure

Start date: January 2011
Phase: Phase 1
Study type: Interventional

The aim of this study is to establish a model for the evaluation of drug targets using postural measures to induce changes in lung water concentration as assessed by MRI. A reduction in the magnitude and rate of water transudation with postural changes in patients with congestive heart failure (CHF) could provide a model for the evaluation of various classes of molecules for target validation and for dose selection.

NCT ID: NCT01197326 Completed - Sepsis Clinical Trials

The Prevention of Failure to Rescue Using Early Warning Scoring

VitalCare
Start date: August 2009
Phase: N/A
Study type: Observational

The purpose of this study is to assess if, compared with standard paper-based systems, an automated Early Warning System (EWS) resident in a spot check patient monitor, can help to identify deteriorating patients.

NCT ID: NCT01162161 Completed - Pulmonary Edema Clinical Trials

Role of Sphingolipids in Pulmonary Edema

09-045
Start date: July 2010
Phase: N/A
Study type: Observational

In this mono-center prospective study, the impact of changes in the sphingolipid metabolism in patients with pulmonary edema will be investigated.

NCT ID: NCT01060969 Completed - Pulmonary Edema Clinical Trials

Tadalafil and Acetazolamide Versus Acetazolamide in Acute Mountain Sickness Prevention

Start date: January 2006
Phase: N/A
Study type: Interventional

To evaluate the additive value of tadalafil given together with Diamox (acetazolamide) in preventing acute mountain sickness in travelers to high altitude areas.

NCT ID: NCT00912158 Completed - Clinical trials for Acute Cardiogenic Pulmonary Edema

Non Invasive Mechanical Ventilation in Acute Cardiogenic Pulmonary Edema

Start date: October 2003
Phase: Phase 4
Study type: Interventional

Cardiogenic pulmonary edema (CPE) is a common medical emergency and noninvasive ventilation (NIV) in addition to conventional medical treatment might be beneficial for patients with CPE.

NCT ID: NCT00829855 Completed - Hypertension Clinical Trials

Echocardiographic Evaluation of Hypertensive Acute Pulmonary Edema

Start date: May 2008
Phase: N/A
Study type: Observational

Acute cardiogenic pulmonary edema (ACPE), one of the most severe forms of acute heart failure, represents 5% of hospital admissions. One of the most frequent phenomena encountered during ACPE is hypertensive crisis (hypertensive ACPE) but the mechanisms and causes of hypertensive ACPE are insufficiently understood. Few studies have evaluated the cardiac function during hypertensive ACPE, and these studies used only conventional echocardiography methods. New methods of evaluation of cardiac function in hypertensive ACPE (such as Tissue Doppler imaging) have not been used. The objectives of this study are to evaluate presence and role of the following potential mechanisms of hypertensive ACPE: 1. acute myocardial dysfunction (systolic and diastolic); 2. silent transient myocardial ischemia; 3. acute mechanical left ventricular dyssynchrony; 4. dynamic mitral regurgitation; 5. inter-ventricular interaction. Conventional and Tissue Doppler echocardiography will be used to assess cardiac function.

NCT ID: NCT00815646 Completed - Clinical trials for Swimming Induced Pulmonary Edema (SIPE)

Prevention and Treatment of Immersion Pulmonary Edema

Start date: January 2008
Phase: Phase 0
Study type: Interventional

Immersion pulmonary edema (IPE) is a condition in which fluid fills the lungs during diving or swimming, particularly in cold water. Some individuals appear to be predisposed to developing IPE. DNA samples will be collected and stored, in order to compare the genetic profiles of individuals who have experienced IPE with those who have not. In a few individuals who have experienced IPE, we plan to measure the effects of cold water immersion on the blood pressure, cardiac output and the pressures in the pulmonary artery. These will be compared with similar measurements already obtained from normal individuals.

NCT ID: NCT00785174 Completed - Clinical trials for Cardiogenic Pulmonary Edema

Non-Invasive Ventilation Versus Continuous Positive Airway Pressure in Cardiogenic Pulmonary Edema: a Multicentre Study

Start date: January 2005
Phase: Phase 3
Study type: Interventional

Non-invasive ventilation (NIV) has become now a widely used treatment modality in ICU and emergency services to deal with respiratory failure.1 NIV has the potential to improve ventilatory assistance while avoiding endotracheal intubation and its complications. Since the first publications of Meduri2 and Brochard3 the number of studies on the NIV has been growing and developing and this technique becomes one of the major progress in the field of respiratory assistance. Decompensation of chronic obstructive pulmonary disease (COPD) is certainly the least questionable indication of the NIV. However, indication of the NIV is inexorably spreading to other types of acute respiratory insufficiency, including acute cardiogenic pulmonary edema (CPE).4 Continuous positive airway pressure (CPAP) is the most currently used non-invasive ventilation usually performed without the use of a ventilator. NIV using pressure support (NIPSV) combined pressure support (inspiratory aid) and positive expiratory pressure as in CPAP. Based on physiological ground, NIPSV would be more performant than CPAP to improve ventilatory parameters and reduce the work breathing in APE. However, this issue is not settled yet. Number of meta-analysis over the last 2 years were devoted to the comparison of CPAP and NISPV,5 so that the scientific evidence is still far from established. In addition, it is not sur that patients enrolled in these studies are representative of all patients with APE. The fact that they were included solely on the basis of clinical criteria, the risk of overlap with other diagnoses is not negligible. Thus the use of markers of heart failure as the BNP (brain natriuretic peptide) would be very useful. On the other hand, the possible deleterious effect of NIPSV on myocardial perfusion is a problem that has not been definitively resolved. Objectives of the study: 1. Compare the efficacy and safety of the NIPSV with those of CPAP in patients presenting to the emergency department with CPE. 2. Compare the two procedures in subgroups of patients with hypercapnia and high BNP concentration.

NCT ID: NCT00751322 Completed - Clinical trials for Blood Protein Disorders

Transfusion-Induced Alterations of Pulmonary and Immune Function in Mechanically Ventilated Patients

TRALI2
Start date: August 2008
Phase: N/A
Study type: Interventional

Specific aim: To test whether transfusion of leukoreduced red cells of lesser storage time (versus conventional storage time) reduces mild alterations in pulmonary function and immune activation in critically ill patients with mechanically ventilated lungs. We propose to perform a prospective, randomized, double-blind clinical trial in critically ill patients whose lungs are mechanically ventilated, and who have orders to receive transfusion of at least one unit of packed red cells, comparing pulmonary function between patients randomly allocated to receive a unit of red cells stored for 5 days or less, with similar patients randomly allocated to receive a unit of red cells stored conventionally (median 21 days). We will test the hypothesis that transfusion of red cells of lesser storage age, (5 days or less) will produce the less changes of pulmonary function and immune activation than will transfusion of red cells of conventional storage age (median 21 days).